A new Australian study shows COVID-19 boosters improve protection against new variants for people with MS, even when taking immune-suppressing treatments.
Consistently high antibodies to a specific protein of the Epstein-Barr virus may predict MS years before disease onset.
Is targeting EBV the key to treating MS? Two new clinical trials are testing antiviral therapies to slow progression and reduce fatigue.
Nurses play a critical role in strengthening economies, improving health systems, and ensuring better outcomes for communities worldwide. MS Australia has released a report outlining what we can do to better support our MS nursing workforce now and into the future.Â
Launched on World MS Day, Living Well with MS is a practical guide to support lifestyle choices in people living with MS, backed by science and lived experience.
Researchers studying identical twins and laboratory models have found that certain gut bacteria may be linked to MS development.
